Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
<br><strong>Background </strong>Pain is a core domain of psoriatic arthritis (PsA). This post hoc analysis evaluated time to pain improvement and the impact of baseline pain severity on pain response in patients with PsA receiving tofacitinib. <br><strong> Methods </...
Auteurs principaux: | de Vlam, K, Ogdie, A, Bushmakin, AG, Cappelleri, JC, Fleischmann, R, Taylor, PC, Azevedo, V, Fallon, L, Woolcott, J, Mease, PJ |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
BMJ Publishing Group
2021
|
Documents similaires
-
Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib
par: de Vlam, K, et autres
Publié: (2018) -
Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
par: Ogdie, A, et autres
Publié: (2018) -
Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
par: de Vlam, K, et autres
Publié: (2022) -
Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
par: Taylor, P, et autres
Publié: (2019) -
Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
par: Taylor, PC, et autres
Publié: (2020)